Trial of failed sickle cell gene-editing therapy shows signs of a possible comeback
The program was halted three years ago after the first patient suffered a serious adverse event, and new developments may revive it.
Read at STAT โFull coverage ยท 10 outlets
- STAT ยท lead
- ReutersAgios scraps sickle cell treatment after trial shows limited benefit
- Chemistry WorldCould Crispr cure HIV?
- NatureA turning point for gene editing in severe blood disorders
- Yale MedicineCasgevy and Lyfgenia: Two Gene Therapies Approved for Sickle Cell Disease
- BioPharma DiveFDA places formal hold on two Intellia CRISPR trials
- Cleveland ClinicTrial of Gene Therapy to Treat Sickle Cell Disease Reports Initial Positive Results
- PBSExperimental gene editing helped a desperately ill baby thrive. Scientists say it could someday treat millions
- BBCHunter syndrome: Boy with rare condition amazes doctors after world-first gene therapy
- MedicalxpressHow a CRISPR sickle cell therapy moved from lab to clinical trial